Cosmos Health Past Earnings Performance

Past criteria checks 0/6

Cosmos Health's earnings have been declining at an average annual rate of -41.5%, while the Healthcare industry saw earnings growing at 7.2% annually. Revenues have been growing at an average rate of 4.3% per year.

Key information

-41.5%

Earnings growth rate

0.4%

EPS growth rate

Healthcare Industry Growth15.7%
Revenue growth rate4.3%
Return on equity-58.3%
Net Margin-60.3%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Cosmos Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:V67A Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2456-34240
30 Jun 2456-29240
31 Mar 2456-27250
31 Dec 2353-26260
30 Sep 2350-43190
30 Jun 2349-42170
31 Mar 2350-59150
31 Dec 2250-64130
30 Sep 2254-3590
30 Jun 2256-35100
31 Mar 2258-19110
31 Dec 2156-16120
30 Sep 2156-7110
30 Jun 2157-590
31 Mar 2155-170
31 Dec 2055150
30 Sep 2051240
30 Jun 2046-140
31 Mar 2042-440
31 Dec 1940-340
30 Sep 1936-1340
30 Jun 1934-940
31 Mar 1935-640
31 Dec 1837-940
30 Sep 1840-250
30 Jun 1841-650
31 Mar 1838-750
31 Dec 1730-650
30 Sep 1723-330
30 Jun 1715-320
31 Mar 1710-310
31 Dec 167-110
30 Sep 164-710
30 Jun 163-710
31 Mar 162-710
31 Dec 151-700
30 Sep 150-100
30 Jun 156400
31 Mar 157500
31 Dec 148600
30 Sep 149700
30 Jun 143200
31 Mar 142100
31 Dec 131000

Quality Earnings: V67A is currently unprofitable.

Growing Profit Margin: V67A is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: V67A is unprofitable, and losses have increased over the past 5 years at a rate of 41.5% per year.

Accelerating Growth: Unable to compare V67A's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: V67A is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (40.5%).


Return on Equity

High ROE: V67A has a negative Return on Equity (-58.3%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 04:00
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cosmos Health Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Howard HalpernTaglich Brothers, Inc.